Study to Assess the Efficacy and Safety of QHRD106 Injection in Acute Ischemic Stroke.
Clinical trial NCT07396337 · RECRUITING
Trial details
- NCT number
- NCT07396337
- Sponsor
- Changzhou Qianhong Bio-pharma Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-19
- Primary completion
- 2026-10-31
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.